Cargando…

LncRNA MIR31HG Drives Oncogenicity by Inhibiting the Limb-Bud and Heart Development Gene (LBH) during Oral Carcinoma

The miR-31 host gene (MIR31HG) encodes a long non-coding RNA (LncRNA) that harbors miR-31 in its intron 2; miR-31 promotes malignant neoplastic progression. Overexpression of MIR31HG and of miR-31 occurs during oral squamous cell carcinoma (OSCC). However, the downstream effectors modulated by MIR31...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Kuo-Wei, Hung, Wan-Wen, Chou, Chung-Hsien, Tu, Hsi-Feng, Chang, Shi-Rou, Liu, Ying-Chieh, Liu, Chung-Ji, Lin, Shu-Chun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395036/ https://www.ncbi.nlm.nih.gov/pubmed/34445087 http://dx.doi.org/10.3390/ijms22168383

Ejemplares similares

Co-upregulation of miR-31 and its host gene lncRNA MIR31HG in oral squamous cell carcinoma
por: Tu, Hsi-Feng, et al.
Publicado: (2022)

Limb‐bud and heart development (LBH) contributes to glioma progression in vitro and in vivo
por: Liu, Luotong, et al.
Publicado: (2021)

miR-31-NUMB Cascade Modulates Monocarboxylate Transporters to Increase Oncogenicity and Lactate Production of Oral Carcinoma Cells
por: Chou, Chung-Hsien, et al.
Publicado: (2021)

Limb-Bud and Heart (LBH) Upregulation in Cardiomyocytes under Hypoxia Promotes the Activation of Cardiac Fibroblasts via Exosome Secretion
por: Xu, Yuling, et al.
Publicado: (2022)

Limb-bud and Heart (LBH) Functions as a Tumor Suppressor of Nasopharyngeal Carcinoma by Inducing G1/S Cell Cycle Arrest
por: Liu, Qicai, et al.
Publicado: (2015)

MIR31HG, a potential lncRNA in human cancers and non-cancers
por: Ruan, Luxi, et al.
Publicado: (2023)

The predictive value of lncRNA MIR31HG expression on clinical outcomes in patients with solid malignant tumors
por: Tu, Chao, et al.
Publicado: (2020)

Overexpression of Limb-Bud and Heart (LBH) promotes angiogenesis in human glioma via VEGFA-mediated ERK signalling under hypoxia
por: Jiang, Yang, et al.
Publicado: (2019)

MIR100HG: a credible prognostic biomarker and an oncogenic lncRNA in gastric cancer
por: Li, Jun, et al.
Publicado: (2019)

Knockdown of lncRNA MIR31HG inhibits cell proliferation in human HaCaT keratinocytes
por: Gao, Jintao, et al.
Publicado: (2018)

LncRNA miR205HG hinders HNRNPA0 translation: anti‐oncogenic effects in esophageal carcinoma
por: Dong, Xiaoying, et al.
Publicado: (2021)

miR-31 targets ARID1A and enhances the oncogenicity and stemness of head and neck squamous cell carcinoma
por: Lu, Wen-Cheng, et al.
Publicado: (2016)

Hypoxia‐inducible lncRNA MIR210HG interacting with OCT1 is involved in glioblastoma multiforme malignancy
por: Ho, Kuo‐Hao, et al.
Publicado: (2021)

LncRNA MIR31HG controls the proliferation and metastasis of gastric cancer by c-CBL-mediated degradation of β-catenin
por: Peng, Wen, et al.
Publicado: (2023)

Elevated limb-bud and heart development (LBH) expression indicates poor prognosis and promotes gastric cancer cell proliferation and invasion via upregulating Integrin/FAK/Akt pathway
por: Yu, Ruoxi, et al.
Publicado: (2019)

A novel cuproptosis-related prognostic lncRNA signature and lncRNA MIR31HG/miR-193a-3p/TNFRSF21 regulatory axis in lung adenocarcinoma
por: Mo, Xiaocong, et al.
Publicado: (2022)

Survival-Related lncRNA Landscape Analysis Identifies LINC01614 as an Oncogenic lncRNA in Gastric Cancer
por: Wu, Huijie, et al.
Publicado: (2021)

LncRNA MIR4435-2HG predicts poor prognosis in patients with colorectal cancer
por: Ouyang, Wen, et al.
Publicado: (2019)

Knockdown of lncRNA MIR31HG inhibits adipocyte differentiation of human adipose-derived stem cells via histone modification of FABP4
por: Huang, Yiping, et al.
Publicado: (2017)

The Concordant Disruption of B7/CD28 Immune Regulators Predicts the Prognosis of Oral Carcinomas
por: Chang, Shi-Rou, et al.
Publicado: (2023)

LncRNA-RMRP Acts as an Oncogene in Lung Cancer
por: Meng, Qingjun, et al.
Publicado: (2016)

Multi-cancer analysis reveals universal association of oncogenic LBH expression with DNA hypomethylation and WNT-Integrin signaling pathways
por: Young, In-Chi, et al.
Publicado: (2023)

Polymorphisms in lncRNA MIR2052HG and susceptibility to breast cancer in Chinese population
por: Yang, Hui, et al.
Publicado: (2021)

LncRNA SNHG15: A new budding star in human cancers
por: Shuai, You, et al.
Publicado: (2019)

LncRNA plasmacytoma variant translocation 1 is an oncogene in bladder urothelial carcinoma
por: Liu, Zhongyuan, et al.
Publicado: (2017)

Silencing of lncRNA MIR31HG promotes nasopharyngeal carcinoma cell proliferation and inhibits apoptosis through suppressing the PI3K/AKT signaling pathway
por: Feng, Bo, et al.
Publicado: (2022)

FEZF1-AS1 functions as an oncogenic lncRNA in retinoblastoma
por: Quan, Lian-Jiao, et al.
Publicado: (2019)

Oncogenic roles of the lncRNA LINC00460 in human cancers
por: Su, Min, et al.
Publicado: (2022)

Overexpression of LBH is associated with poor prognosis in human hepatocellular carcinoma
por: Chen, Jiewei, et al.
Publicado: (2018)

Hypoxia induced LBH overexpression accelerates malignant progression in glioma
por: Zhang, Ke-Nan, et al.
Publicado: (2019)

LncRNA MIR31HG targets HIF1A and P21 to facilitate head and neck cancer cell proliferation and tumorigenesis by promoting cell-cycle progression
por: Wang, Ru, et al.
Publicado: (2018)

LncRNA miR503HG interacts with miR-31-5p through multiple ways to regulate cancer cell invasion and migration in ovarian cancer
por: Zhu, Ding, et al.
Publicado: (2020)

A Positive Feedback Loop of lncRNA MIR31HG-miR-361-3p -YY1 Accelerates Colorectal Cancer Progression Through Modulating Proliferation, Angiogenesis, and Glycolysis
por: Guo, Tao, et al.
Publicado: (2021)

LncRNA MIR4435-2HG is downregulated in osteoarthritis and regulates chondrocyte cell proliferation and apoptosis
por: Xiao, Yu, et al.
Publicado: (2019)

LncRNA MIR155HG Overexpression Promotes Proliferation, Migration, and Chemoresistance in Gastric Cancer Cells
por: Lin, Hong, et al.
Publicado: (2023)

LncmiRHG-MIR100HG: A new budding star in cancer
por: Wu, Yingnan, et al.
Publicado: (2022)

LncRNA SNHG3, a potential oncogene in human cancers
por: Xu, Bin, et al.
Publicado: (2020)

LncRNA H19: A novel oncogene in multiple cancers
por: Yang, Jun, et al.
Publicado: (2021)

lncRNA PVT1: a novel oncogene in multiple cancers
por: Li, Ruiming, et al.
Publicado: (2022)

LncRNA FOXD1‐AS1 acts as a potential oncogenic biomarker in glioma
por: Gao, Yuan‐Feng, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_u3jjobusjj5v13g6vhk1qbn2ft